DENTSPLY SIRONA (NASDAQ:XRAY) Lowered to "Hold" Rating by Leerink Partnrs

Leerink Partnrs cut shares of DENTSPLY SIRONA (NASDAQ:XRAY - Free Report) from a strong-buy rating to a hold rating in a report published on Thursday morning,Zacks.com reports.

Several other equities research analysts also recently issued reports on the company. Robert W. Baird cut their price target on DENTSPLY SIRONA from $31.00 to $24.00 and set a "neutral" rating for the company in a report on Friday. Stifel Nicolaus cut their price target on DENTSPLY SIRONA from $30.00 to $28.00 and set a "hold" rating for the company in a report on Thursday, July 18th. Evercore ISI lowered their price objective on DENTSPLY SIRONA from $29.00 to $27.00 and set an "outperform" rating on the stock in a research report on Tuesday, October 8th. Needham & Company LLC lowered their price objective on DENTSPLY SIRONA from $34.00 to $29.00 and set a "buy" rating on the stock in a research report on Friday, October 25th. Finally, Barrington Research lowered their price objective on DENTSPLY SIRONA from $36.00 to $24.00 and set an "outperform" rating on the stock in a research report on Friday. Six investment analysts have rated the stock with a hold rating and five have given a buy rating to the company. Based on data from MarketBeat.com, DENTSPLY SIRONA presently has a consensus rating of "Hold" and a consensus target price of $29.50.

DENTSPLY SIRONA Stock Up 3.5 %

Shares of XRAY traded up $0.60 during mid-day trading on Thursday, hitting $17.86. 9,705,924 shares of the company's stock were exchanged, compared to its average volume of 3,115,189. The company has a market cap of $3.62 billion, a PE ratio of -8.63, a P/E/G ratio of 1.31 and a beta of 1.02. DENTSPLY SIRONA has a 52 week low of $17.21 and a 52 week high of $37.60. The company has a 50-day simple moving average of $24.68 and a 200 day simple moving average of $25.90. The company has a debt-to-equity ratio of 0.57, a current ratio of 1.33 and a quick ratio of 0.87.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last released its quarterly earnings data on Thursday, November 7th. The medical instruments supplier reported $0.50 EPS for the quarter, beating the consensus estimate of $0.48 by $0.02. The company had revenue of $951.00 million during the quarter, compared to the consensus estimate of $939.10 million. DENTSPLY SIRONA had a positive return on equity of 11.86% and a negative net margin of 4.75%. The firm's revenue for the quarter was up .4% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.49 EPS. On average, research analysts forecast that DENTSPLY SIRONA will post 1.98 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of XRAY. UMB Bank n.a. grew its position in DENTSPLY SIRONA by 430.3% in the third quarter. UMB Bank n.a. now owns 928 shares of the medical instruments supplier's stock valued at $25,000 after acquiring an additional 753 shares during the last quarter. Capital Performance Advisors LLP acquired a new stake in shares of DENTSPLY SIRONA during the third quarter valued at about $27,000. LRI Investments LLC boosted its stake in shares of DENTSPLY SIRONA by 82.7% during the second quarter. LRI Investments LLC now owns 1,246 shares of the medical instruments supplier's stock valued at $31,000 after purchasing an additional 564 shares in the last quarter. Rothschild Investment LLC acquired a new stake in shares of DENTSPLY SIRONA during the second quarter valued at about $32,000. Finally, Kennebec Savings Bank acquired a new stake in shares of DENTSPLY SIRONA during the third quarter valued at about $35,000. Institutional investors own 95.70% of the company's stock.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.